|
MYLIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17929999998712E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.11930000000504E-05 |
| Normal-vs-Stage2 |
1.223090E-03 |
| Normal-vs-Stage3 |
1.74049999968062E-08 |
| Normal-vs-Stage4 |
4.21479999790364E-08 |
| Stage1-vs-Stage2 |
9.434400E-01 |
| Stage1-vs-Stage3 |
2.305900E-02 |
| Stage1-vs-Stage4 |
5.641700E-04 |
| Stage2-vs-Stage3 |
8.981700E-02 |
| Stage2-vs-Stage4 |
1.555660E-02 |
| Stage3-vs-Stage4 |
1.263560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.82590000014282E-07 |
| Normal-vs-AfricanAmerican |
2.380300E-03 |
| Normal-vs-Asian |
5.384800E-03 |
| Caucasian-vs-AfricanAmerican |
1.578240E-01 |
| Caucasian-vs-Asian |
8.592200E-01 |
| AfricanAmerican-vs-Asian |
4.326000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.67160000011479E-07 |
| Normal-vs-Female |
7.117000E-03 |
| Male-vs-Female |
8.835900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.75660999999216E-05 |
| Normal-vs-Extreme_Weight |
1.90089999999588E-05 |
| Normal-vs-Obese |
9.97080000000317E-05 |
| Normal-vs-Extreme_Obese |
4.184000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.363800E-01 |
| Normal_Weight-vs-Obese |
2.671000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.982400E-01 |
| Extreme_Weight-vs-Obese |
6.241800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.358600E-01 |
| Obese-vs-Extreme_Obese |
5.138400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.481600E-03 |
| Normal-vs-Age(41-60Yrs) |
6.209700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.1524000005122E-07 |
| Normal-vs-Age(81-100Yrs) |
6.55879999977849E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.845200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.085200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.237500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.960400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.884400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.627040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.351000E-04 |
| Normal-VS-Type2 PRCC |
2.36419994692483E-10 |
| Normal-VS-KIRP CIMP |
2.25330000003243E-06 |
| Normal-VS-Unclassified PRCC |
6.441900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.60609999999961E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.757600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.489400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.509400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.103700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.843700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36140000051022E-07 |
| Normal-vs-N1 |
7.451100000333E-07 |
| Normal-vs-N2 |
3.61110000000053E-05 |
| N0-vs-N1 |
7.109000E-01 |
| N0-vs-N2 |
1.176830E-03 |
| N1-vs-N2 |
2.189800E-02 |
|
|
